Locus for the inducible, but not a constitutive, nitric oxide synthase cosegregates with blood pressure in the Dahl salt-sensitive rat

The Journal of Clinical Investigation
A Y Deng, J P Rapp

Abstract

Alleles of the inducible nitric oxide synthase locus (Nos2) cosegregated highly significantly (P < 0.0001) with blood pressure in an F2 population [F2(S x MNS), n = 171] derived from a cross of inbred Dahl salt-sensitive (S) rats with Milan normotensive rats (MNS). In contrast, alleles at the constitutive brain nitric oxide synthase locus (Nos1) did not cosegregate with blood pressure in several F2 populations. Nos2 was mapped on rat chromosome 10. Nine genetic markers, including the angiotensin-converting enzyme (Ace) and Nos2 loci spanning roughly 46 cM on rat chromosome 10, all cosegregated strongly with blood pressure in the F2(S x MNS) population. Nos2 showed the highest LOD score of 6.3. Ace and Nos2 are 30 cM apart. In an F2 population [F2(S x WKY), n = 159] derived from a cross of S rats with Wistar-Kyoto (WKY) rats, Nos2 alleles did (P = 0.0070), but Ace alleles did not (P = 0.91), cosegregate with blood pressure. We conclude that the Nos2 locus rather than the Nos1 locus is a candidate for influencing blood pressure in the S rat. There are probably two separate but linked quantitative trait loci (QTL) for blood pressure on rat chromosome 10, one marked by Ace and the other marked by Nos2. In F2(S x MNS) functionally v...Continue Reading

References

Apr 15, 1992·Biochemical and Biophysical Research Communications·R Y ZeeB J Morris
Jul 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S LamasT Michel
Jan 1, 1992·Mammalian Genome : Official Journal of the International Mammalian Genome Society·T KuniedaT Imamichi
Nov 1, 1991·The Journal of Clinical Investigation·P Y Chen, P W Sanders
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M W RadomskiS Moncada
Jan 1, 1990·Annual Review of Pharmacology and Toxicology·L J Ignarro
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D D ReesS Moncada
Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·L J IgnarroG Chaudhuri
Nov 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·I SakumaR Levi
Feb 15, 1994·Biochemical and Biophysical Research Communications·S NadaudF Soubrier
May 1, 1994·Mammalian Genome : Official Journal of the International Mammalian Genome Society·I C GerlingE H Leiter
Feb 26, 1993·Biochemical and Biophysical Research Communications·Y NunokawaS Tanaka
Mar 31, 1993·Biochemical and Biophysical Research Communications·E R WoodE G Lapetina
Nov 1, 1994·Mammalian Genome : Official Journal of the International Mammalian Genome Society·A Y DengJ Szpirer
Jul 1, 1994·The Journal of Clinical Investigation·A Y DengJ P Rapp
Feb 1, 1994·Mammalian Genome : Official Journal of the International Mammalian Genome Society·J YamadaT Serikawa

❮ Previous
Next ❯

Citations

Dec 1, 1996·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·E F RemmersR L Wilder
Nov 1, 1995·Mammalian Genome : Official Journal of the International Mammalian Genome Society·A Y DengM T Bihoreau
May 6, 2010·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Sivarajan KumarasamyBina Joe
Apr 1, 1997·Mammalian Genome : Official Journal of the International Mammalian Genome Society·O I DukhaninaJ P Rapp
Jan 22, 1998·Mammalian Genome : Official Journal of the International Mammalian Genome Society·A Y DengJ P Rapp
Jan 7, 1999·Physiology & Behavior·M A BayorhV M Chenault
Dec 20, 2000·General Pharmacology·S Andreopoulos, A Papapetropoulos
Apr 15, 2003·Trends in Cardiovascular Medicine·Gavin Y OuditJosef M Penninger
Jan 1, 1997·Trends in Cardiovascular Medicine·K Sase, T Michel
Apr 5, 2003·Annals of Human Genetics·J KnightM J Caulfield
Aug 5, 1998·Kidney International·D Cusi, G Bianchi
Jun 2, 1998·Kidney International·Y Yagil, C Yagil
Jul 27, 1995·The New England Journal of Medicine·J Loscalzo
Feb 5, 2013·Current Opinion in Nephrology and Hypertension·Miki Nagase
Jun 1, 1996·Clinical and Experimental Pharmacology & Physiology·L R FriendL R Griffiths
Mar 1, 1996·Heart·K Bhagat, P Vallance
Feb 1, 1996·The Journal of Clinical Investigation·L GuJ P Rapp
Apr 27, 2007·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Naomi YasuiNaoharu Iwai
Mar 21, 1998·Clinical and Experimental Hypertension : CHE·A Y Deng
Oct 16, 2008·Clinical and Experimental Hypertension : CHE·Alan Y DengJulie Roy
Jun 16, 1999·Clinical and Experimental Hypertension : CHE·M A BayorhT C Chu
Jul 11, 2003·Biochimica Et Biophysica Acta·Zhenmin Ni, Nosratola D Vaziri
Jul 8, 2003·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·S A GouvêaG R Abreu
Jul 16, 1999·Clinical and Experimental Pharmacology & Physiology·N Kato
Feb 4, 1998·Hypertension·D L MattsonA W Cowley
Mar 8, 2003·Hypertension·Julie Y H ChanSamuel H H Chan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.